We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Quanta Services
PWR
$104B
| $6.06M | 0.03% |
16,031
+3,560
| +29% | +$1.14M |
|
527
American Electric Power
AEP
$69.9B
| $6M | 0.03% |
57,783
-17,265
| -23% | -$1.8M |
|
528
Digital Realty Trust
DLR
$71.7B
| $5.97M | 0.03% |
34,247
-290,404
| -89% | -$47.5M |
|
|
JBS
529
JBS N.V.
JBS
$44.8B
| $5.91M | 0.03% |
+404,526
| New | +$5.69M |
|
530
Rivian
RIVN
$22.8B
| $5.78M | 0.03% |
+420,868
| New | +$5.71M |
|
531
Dine Brands
DIN
$442M
| $5.77M | 0.03% |
+237,063
| New | +$5.48M |
|
|
BRR
532
ProCap Financial Inc
BRR
$161M
| $5.73M | 0.03% |
+500,000
| New | +$5.93M |
|
533
Realty Income
O
$58.7B
| $5.63M | 0.03% |
97,684
+23,742
| +32% | +$1.34M |
|
534
Gates Industrial Corporation Ltd.
GTES
$7.55B
| $5.61M | 0.03% |
+243,451
| New | +$4.91M |
|
535
Cencora
COR
$59.6B
| $5.6M | 0.03% |
+18,661
| New | +$5.38M |
|
536
Marathon Petroleum
MPC
$91.3B
| $5.52M | 0.03% |
33,232
+6,535
| +24% | +$980K |
|
537
Oneok
OKE
$55.2B
| $5.52M | 0.03% |
67,566
+15,148
| +29% | +$1.26M |
|
538
Thermo Fisher Scientific
TMO
$209B
| $5.5M | 0.03% |
+13,559
| New | +$5.67M |
|
539
Ameriprise Financial
AMP
$48.9B
| $5.5M | 0.03% |
10,300
-63,231
| -86% | -$31.2M |
|
540
Dyne Therapeutics
DYN
$4.85B
| $5.47M | 0.03% |
574,853
+418
| +0.1% | +$4.6K |
|
541
Nice
NICE
$6.05B
| $5.46M | 0.03% |
32,352
+12,212
| +61% | +$1.97M |
|
542
FedEx
FDX
$74.1B
| $5.42M | 0.03% |
23,845
-111,454
| -82% | -$24.4M |
|
543
Sempra
SRE
$56.6B
| $5.35M | 0.03% |
70,544
+17,032
| +32% | +$1.26M |
|
544
CytomX Therapeutics
CTMX
$723M
| $5.3M | 0.03% |
2,336,899
+679,593
| +41% | +$1.1M |
|
545
United Rentals
URI
$71.6B
| $5.3M | 0.03% |
7,031
+1,513
| +27% | +$1.01M |
|
|
SFD
546
Smithfield Foods
SFD
$9.97B
| $5.28M | 0.03% |
+224,367
| New | +$4.96M |
|
|
CNTA
547
DELISTED
Centessa Pharmaceuticals
CNTA
| $5.26M | 0.03% |
400,278
| – | – |
|
548
Phillips 66
PSX
$82.5B
| $5.26M | 0.03% |
44,072
+9,181
| +26% | +$1.03M |
|
549
ARS Pharmaceuticals
SPRY
$528M
| $5.24M | 0.03% |
300,419
-299,903
| -50% | -$4.33M |
|
550
Dominion Energy
D
$60.9B
| $5.21M | 0.03% |
92,245
+21,277
| +30% | +$1.17M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.